IRS2 amplification
|
CRC
|
IRS2 amplification
|
CRC
|
EGFR inhibitor Sensitive: C3 – Early Trials
|
EGFR inhibitor Sensitive: C3 – Early Trials
|
IRS2 amplification
|
CRC
|
IRS2 amplification
|
CRC
|
BMS-754807 Sensitive: D – Preclinical
|
BMS-754807 Sensitive: D – Preclinical
|